Sign Up Now! Sign up for news alerts, special features and commentary about stents and more. Drug-Eluting Stent Overview     Drug-eluting stents (a.k.a. "coated" or "medicated" stents) were developed to solve one of the biggest problems of interventional coronary treatment: restenosis -- or reclosure of the artery. (Read more...) Late Stent Thrombosis Reports presented at the 2006 World Congress of Cardiology and to a special FDA panel have called attention to potential problems with drug-eluting stents. What does this mean for patients? (Read more...)     NewsCenter: Reports and Features Breaking news, original reporting and links to research about drug-eluting stents: •  Medtronic ENDEAVOR IV Drug-Eluting Stent Clinical Trial Meets Primary Endpoint (July 2) •  Cordis Resolves FDA CYPHER Stent Warning Letter (June 15) •  Abbott XIENCE™ Drug-Eluting Stent Submitted for FDA Approval (June 1) •  Most Heart Stents Are Placed Imperfectly, Increasing Risk of Heart Attack or Reclosure (May 30) •  No Late Stent Thrombosis for Medtronic Endeavor Drug-Eluting Stent (May 22) •  Problems Resurface with Drug-Eluting Stents (Sept 4 2006) •  All Drug-Eluting Stents News With thousands of postings, Angioplasty.Org's Forum is an active patient community with discussions on drug-eluting stents, antiplatelet therapy and more.

Answers to Top Ten Questions About Stents & Angioplasty vs. Drug Therapy The COURAGE Trial was an important study, but reports about it have caused confusion for patients and physicians. (Read more...)     Patient Advocate Tells FDA Drug-Eluting Stent Safety Panel: Public Deserves Better     On the first day of the FDA's advisory panel hearings on drug-eluting stent safety, editor Burt Cohen of Angioplasty.Org was the lone voice on behalf of concerned patients. (Read more...) Problems Resurface with Drug-Eluting Stents Questions about late stent thrombosis in drug-eluting stents were very publicly raised at the World Congress of Cardiology meeting in September 2006, leading to a number of meetings that have attempted to deal with the issue. (Read more...)     Angioplasty.Org Interview with: Gregg W. Stone, MD    Dr. Stone is Director of Cardiovascular Research and Education at New York-Presbyterian Hospital / Columbia University Medical Center. He is one of the world's leading interventional cardiologists and was principal investigator for the TAXUS IV drug-eluting stent clinical trial..

Angioplasty.Org Home •  PatientCenter

send comments & suggestions to "info at angioplasty dot org"
read Terms of Use and Privacy statement

Angioplasty.org is an independent educational health site
which receives support from
Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2008